• Manhattan Sports Therapy Opens Newly Renovated Midtown Facility on Madison Avenue Yahoo Finance Wed, 08 Jul 2026 13:02:00 GMT
• Enterprise value to EBITDA forward of Avenue Therapeutics, Inc. – OTC:ATXI TradingView Sat, 04 Jul 2026 11:47:07 GMT
• price to sales forward of avenue therapeutics, inc. – otc:atxi TradingView Mon, 29 Jun 2026 19:27:52 GMT
• price to book forward of avenue therapeutics, inc. – otc:atxi TradingView Fri, 26 Jun 2026 05:28:09 GMT
• price to sales forward of avenue therapeutics, inc. – lsx:a40bwj TradingView Thu, 25 Jun 2026 22:12:19 GMT
• enterprise value to ebitda forward of avenue therapeutics, inc. – lsx:a40bwj TradingView Thu, 25 Jun 2026 21:25:19 GMT
• enterprise value to revenue forward of avenue therapeutics, inc. – lsx:a40bwj TradingView Thu, 25 Jun 2026 18:49:22 GMT
• price to earnings forward of avenue therapeutics, inc. – lsx:a40bwj TradingView Thu, 25 Jun 2026 17:23:20 GMT
• avenue therapeutics, inc. actuals & estimates (otc:atxi) TradingView Thu, 25 Jun 2026 13:44:52 GMT
• fortress biotech stock - saturday deep dive on the business model AD HOC NEWS Sat, 20 Jun 2026 18:43:29 GMT
• Madison Avenue Partners LP Reduces Stock Holdings in Keros Therapeutics, Inc. $KROS MarketBeat Thu, 18 Jun 2026 07:00:00 GMT
• copper-containing drug reduces toxic proteins in alzheimer's, improves cognition, study suggests ETPharma.com Mon, 15 Jun 2026 12:13:27 GMT
• lab trials prove copper therapy enhances cognitive function and spatial learning News-Medical Mon, 15 Jun 2026 04:11:00 GMT
• tango therapeutics announces proposed $500 million public offering The Manila Times Mon, 08 Jun 2026 20:06:39 GMT
• click therapeutics positions over-the-counter digital therapeutics as new growth avenue TipRanks Wed, 13 May 2026 00:48:10 GMT
• click therapeutics positions over-the-counter digital therapeutics as new growth avenue TipRanks Tue, 12 May 2026 07:00:00 GMT
• turn therapeutics reports first quarter 2026 financial results and provides corporate updates BioSpace Tue, 12 May 2026 07:00:00 GMT
• Turn Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updates Business Wire Mon, 11 May 2026 07:00:00 GMT
• avenue therapeutics, inc. 1q 2026: net loss $0.7m, revenue $0— 10-q summary TradingView Fri, 08 May 2026 12:41:01 GMT
• avenue therapeutics, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Fri, 08 May 2026 12:33:00 GMT
• avenue therapeutics (otc: atxi) cuts q1 loss but warns on going concern Stock Titan Fri, 08 May 2026 07:00:00 GMT
• why definium therapeutics’ lsd-based drug has wall street watching 2026 TechStock² Sat, 18 Apr 2026 19:27:57 GMT
• kailera therapeutics announces pricing of initial public offering GlobeNewswire Thu, 16 Apr 2026 07:00:00 GMT
• CALR Mutation–Directed Agents and Targeted Therapies Represent Key Research Avenue in MPN Management OncLive Wed, 15 Apr 2026 07:00:00 GMT
• form 10-k - annual report [section 13 and 15(d), not s-k item 405] ADVFN Sun, 12 Apr 2026 19:27:06 GMT
• avenue therapeutics (atxi) eps diluted (ttm) Zacks Investment Research Thu, 02 Apr 2026 22:15:03 GMT
• wall street sees multi-billion dollar debut for lilly's obesity pill despite novo lead Reuters Thu, 02 Apr 2026 07:00:00 GMT
• axsome therapeutics acquires selective pde10a inhibitor balipodect for the treatment of schizophrenia and other neuropsychiatric c... Yahoo Finance Wed, 01 Apr 2026 07:00:00 GMT
• fortress biotech reports 2025 financial results and recent corporate highlights The Manila Times Wed, 01 Apr 2026 07:00:00 GMT
• avenue therapeutics focuses on neurologic disease therapies with atx-04 and iv tramadol as key product candidates in 2026 Minichart Tue, 31 Mar 2026 09:47:00 GMT
• Fortress Biotech Reports 2025 Financial Results and Recent Corporate Highlights GlobeNewswire Tue, 31 Mar 2026 07:00:00 GMT
• fortress biotech (nasdaq: fbio) turns 2025 profit with $205m prv sale and new royalties Stock Titan Tue, 31 Mar 2026 07:00:00 GMT
• rare disease drug wins fda nod as fortress unit sells voucher for $205m Stock Titan Tue, 31 Mar 2026 07:00:00 GMT
• avenue therapeutics, inc. reports earnings results for the full year ended december 31, 2025 marketscreener.com Mon, 30 Mar 2026 07:00:00 GMT
• atxi: 2025 net loss narrowed to $2.9m as focus shifts to atx-04 and iv tramadol amid funding challenges TradingView — Track All Markets Mon, 30 Mar 2026 07:00:00 GMT
• avenue therapeutics, inc. auditor raises 'going concern' doubt marketscreener.com Sun, 29 Mar 2026 07:00:00 GMT
• turn therapeutics secures up to $25 million financing from avenue capital to advance atopic dermatitis and onychomycosis programs Minichart Wed, 25 Mar 2026 07:00:00 GMT
• turn therapeutics secures up to $25m in financing from avenue capital group MSN Tue, 24 Mar 2026 19:54:33 GMT
• turn therapeutics, inc. secures up to $25 million in financing from avenue capital group MarketScreener Tue, 24 Mar 2026 12:00:00 GMT
• Turn Therapeutics Secures Up to $25 Million in Financing From Avenue Capital Group Business Wire Tue, 24 Mar 2026 07:00:00 GMT
• turn therapeutics secures $25m loan facility from avenue capital Investing.com Tue, 24 Mar 2026 07:00:00 GMT
• turn therapeutics secures up to $25 million term loan facility from avenue venture opportunities TradingView Tue, 24 Mar 2026 07:00:00 GMT
• turn therapeutics secures up to $25 million financing from avenue capital group for product pipeline expansion geneonline.com Tue, 24 Mar 2026 07:00:00 GMT
• discovery of shp protein reveals promising new avenue for osteoarthritis therapy by protecting cartilage Bioengineer.org Fri, 20 Mar 2026 15:41:36 GMT
• atxi sec filings - avenue therapeutics inc 10-k, 10-q, 8-k forms Stock Titan Fri, 20 Mar 2026 04:04:36 GMT
• fda-approved cancer drug fedratinib reshapes how cell organelles communicate, providing new therapeutic avenues | newswise Newswise Fri, 13 Mar 2026 07:00:00 GMT
• novel compounds open new research avenues for alzheimer's disease therapeutics Medical Xpress Fri, 13 Mar 2026 07:00:00 GMT
• neurology stocks rebound in 2025 after midyear slump BioWorld MedTech Thu, 12 Mar 2026 07:00:00 GMT
• tangible book value per share of avenue therapeutics, inc. – ls:a40bwj TradingView Sun, 08 Mar 2026 03:40:06 GMT
• net current asset value per share of avenue therapeutics, inc. – ls:a40bwj TradingView Sun, 08 Mar 2026 01:12:45 GMT
• esperion therapeutics stock hits near 1-year high as wall street sees strong risk-reward play on demand for cholesterol drug Stocktwits Thu, 05 Mar 2026 08:00:00 GMT
• deal watch: esperion augments cardiovascular franchise via corstasis buyout Citeline News & Insights Tue, 03 Mar 2026 08:00:00 GMT
• atxi stock news today | earnings, events & price alerts Intellectia AI Sat, 28 Feb 2026 05:46:15 GMT
• Avenue Therapeutics to develop add-on Pompe disease treatment Pompe Disease News Thu, 26 Feb 2026 08:00:00 GMT
• Genetic medicines for epilepsy: unlocking new avenues for seizure control Frontiers Wed, 25 Feb 2026 12:55:50 GMT
• avenue therapeutics licenses atx-04 for pompe disease The Globe and Mail Tue, 24 Feb 2026 08:00:00 GMT
• Avenue Therapeutics Enters into Exclusive Worldwide License GlobeNewswire Mon, 23 Feb 2026 08:00:00 GMT
• axsome (axsm) sales jump 66% to $638m; eyes april fda date grafa.com Mon, 23 Feb 2026 08:00:00 GMT
• rare muscle disease drug deal: avenue backs atx-04 for pompe Stock Titan Mon, 23 Feb 2026 08:00:00 GMT
• avenue therapeutics licenses atx-04 for pompe disease treatment Investing.com Mon, 23 Feb 2026 08:00:00 GMT
• avenue therapeutics (otc: atxi) licenses atx-04 pompe therapy from duke Stock Titan Mon, 23 Feb 2026 08:00:00 GMT
• ikarian capital discloses 4.1% avenue therapeutics (atxi) stake in 13g/a Stock Titan Tue, 17 Feb 2026 08:00:00 GMT
• edgewise therapeutics (nasdaq:ewtx) upgraded at wall street zen MarketBeat Sun, 15 Feb 2026 07:02:00 GMT
• anchor line partners, llc and northwood investors, llc secures 98,500 s/f lease stoke therapeutics at 245 fifth ave. NEREJ Fri, 13 Feb 2026 08:00:00 GMT
• eli lilly to buy biotech orna therapeutics for up to $2.4 billion WSJ Mon, 09 Feb 2026 08:00:00 GMT
• axsome therapeutics says axs-12 nda submission on track for january MSN Tue, 03 Feb 2026 18:19:54 GMT
• sangamo therapeutics (nasdaq:sgmo) downgraded by wall street zen to strong sell MarketBeat Sat, 31 Jan 2026 08:00:00 GMT
• Stoke Therapeutics picks Waltham for expanded headquarters as city’s life sciences sector grows Waltham Times Thu, 29 Jan 2026 08:00:00 GMT
• douglas elliman (nyse:doug) vs. lsl property (otcmkts:lslpf) financial comparison Defense World Wed, 28 Jan 2026 08:00:00 GMT
• caspian services (otcmkts:cssv) vs. dawson geophysical (nasdaq:dwsn) head-to-head review Defense World Wed, 28 Jan 2026 08:00:00 GMT
• tmc the metals (nasdaq:tmc) vs. canadian zeolite (otcmkts:izcff) critical review Defense World Wed, 28 Jan 2026 08:00:00 GMT
• head-to-head review: sonova (otcmkts:sonvy) versus covalon technologies (otcmkts:cvalf) Defense World Wed, 28 Jan 2026 08:00:00 GMT
• invesco pharmaceuticals etf (nysearca:pjp) short interest up 481.9% in january Defense World Wed, 28 Jan 2026 08:00:00 GMT
• boku (lon:boku) insider jonathan peter prideaux sells 325,000 shares of stock Defense World Wed, 28 Jan 2026 08:00:00 GMT
• triumph financial (nyse:tfin) shares gap up on better-than-expected earnings Defense World Wed, 28 Jan 2026 08:00:00 GMT
• financial contrast: urogen pharma (nasdaq:urgn) vs. tscan therapeutics (nasdaq:tcrx) Defense World Wed, 28 Jan 2026 06:46:31 GMT
• head-to-head contrast: actinium pharmaceuticals (nyse:atnm) versus avenue therapeutics (nasdaq:atxi) Defense World Wed, 28 Jan 2026 06:46:31 GMT
• reviewing ibio (nyse:ibio) & aerovate therapeutics (nasdaq:avte) Defense World Wed, 28 Jan 2026 06:46:31 GMT
• meyer burger technology (otcmkts:mybuf) & enphase energy (nasdaq:enph) financial contrast Defense World Wed, 28 Jan 2026 06:46:31 GMT
• galp energia sgps (otcmkts:glpey) and amerilithium (otcmkts:pttn) head-to-head survey Defense World Wed, 28 Jan 2026 06:46:31 GMT
• reviewing umc (otcmkts:umcn) and black diamond group (otcmkts:bdimf) Defense World Wed, 28 Jan 2026 06:46:31 GMT
• contrasting acres commercial realty (nyse:acr) & agnc investment (nasdaq:agnc) Defense World Wed, 28 Jan 2026 06:46:31 GMT
• contrasting brookfield renewable (nyse:bepc) & cheniere energy partners (nyse:cqp) Defense World Wed, 28 Jan 2026 06:46:31 GMT
• hca healthcare (nyse:hca) shares gap up after earnings beat Defense World Wed, 28 Jan 2026 06:41:30 GMT
• jpmorgan u.s. value factor etf (nysearca:jval) short interest up 501.5% in january Defense World Wed, 28 Jan 2026 06:41:30 GMT
• putnam premier income trust (nyse:ppt) short interest update Defense World Wed, 28 Jan 2026 06:41:30 GMT
• agilysys (nasdaq:agys) shares gap down on disappointing earnings Defense World Wed, 28 Jan 2026 06:41:30 GMT
• scotiabank upgrades eldorado gold (tse:eld) to “strong-buy” Defense World Wed, 28 Jan 2026 06:36:28 GMT
• anchor line partners supports stoke therapeutics' growth by securing a 98,500 square-foot lease in waltham, ma Yahoo Finance Tue, 27 Jan 2026 08:00:00 GMT
• huge waltham lab lease fuels work on potential dravet syndrome drug Stock Titan Tue, 27 Jan 2026 08:00:00 GMT
• more cash flows into biotechs during conference week: finance report BioCentury Fri, 16 Jan 2026 08:00:00 GMT
• avenue therapeutics shareholders elect directors, ratify kpmg auditor MSN Tue, 13 Jan 2026 20:32:36 GMT
• gossamer bio, inc. (nasdaq:goss) given average recommendation of “moderate buy” by analysts Defense World Tue, 13 Jan 2026 08:00:00 GMT
• investors support avenue biosciences to advance protein engineering finance.coin-turk.com Mon, 12 Jan 2026 13:30:49 GMT
• avenue biosciences: $5.7 million seed extension raised to scale secretory pathway platform for therapeutic protein manufacturing Pulse 2.0 Mon, 12 Jan 2026 08:00:00 GMT
• avenue biosciences raises $5.7 million seed extension to scale protein manufacturing platform - arcticstartup ArcticStartup Mon, 12 Jan 2026 08:00:00 GMT
• finnish startup avenue biosciences secures €4.8 million to help drugmakers manufacture proteins more reliably BeBeez International Mon, 12 Jan 2026 08:00:00 GMT
• avenue biosciences raises $5.7m to scale its protein engineering technology University of Helsinki Mon, 12 Jan 2026 08:00:00 GMT
• capricor therapeutics (nasdaq:capr) cut to sell at wall street zen MarketBeat Sun, 11 Jan 2026 08:00:00 GMT
• head-to-head analysis: materion (nyse:mtrn) and silver standard resources (nasdaq:ssrm) Defense World Mon, 05 Jan 2026 08:00:00 GMT
• capricor therapeutics (nasdaq:capr) upgraded at wall street zen MarketBeat Sat, 03 Jan 2026 08:00:00 GMT
• kyverna therapeutics (nasdaq:kytx) rating lowered to "sell" at wall street zen MarketBeat Sat, 03 Jan 2026 08:00:00 GMT
• avenue therapeutics provides regulatory update on iv tramadol and other corporate updates ADVFN Sat, 03 Jan 2026 05:36:32 GMT
• axsome therapeutics says axs-12 nda submission on track for january TipRanks Wed, 31 Dec 2025 18:58:13 GMT
• axsome stock gets buy rating from td cowen on fda priority review Investing.com UK Wed, 31 Dec 2025 15:09:46 GMT
• avenue therapeutics (atxi) investors reelect six directors and ratify kpmg for 2025 Stock Titan Wed, 31 Dec 2025 14:49:04 GMT
• avenue therapeutics shareholders elect directors, ratify kpmg auditor TipRanks Wed, 31 Dec 2025 08:00:00 GMT
• atxi: all director nominees were elected and kpmg llp was ratified as auditor for 2025 TradingView — Track All Markets Tue, 30 Dec 2025 15:49:01 GMT
• atxi: all directors were elected and kpmg llp was ratified as auditor for 2025 TradingView Tue, 30 Dec 2025 08:00:00 GMT
• avenue therapeutics shareholders elect directors, ratify kpmg auditor TipRanks Tue, 30 Dec 2025 08:00:00 GMT
• dyne therapeutics (nasdaq:dyn) stock rating lowered by wall street zen MarketBeat Sun, 28 Dec 2025 06:31:21 GMT
• neximmune (nasdaq:nexi) versus avenue therapeutics (nasdaq:atxi) head-to-head comparison Defense World Thu, 25 Dec 2025 08:20:04 GMT
• axsome therapeutics stock hits all-time high at 152.98 usd Investing.com Fri, 19 Dec 2025 08:00:00 GMT
• axsome therapeutics (axsm) receives a buy from wells fargo The Globe and Mail Fri, 19 Dec 2025 08:00:00 GMT
• axsome therapeutics (axsm) gets a buy from jefferies The Globe and Mail Thu, 18 Dec 2025 08:00:00 GMT
• atxi sec filings - avenue therapeutics inc 10-k, 10-q, 8-k forms Stock Titan Mon, 15 Dec 2025 22:23:30 GMT
• rbc capital sticks to its buy rating for axsome therapeutics (axsm) The Globe and Mail Sat, 13 Dec 2025 08:00:00 GMT
• Exosomal non-coding RNAs: a new avenue for treating diabetic foot ulcers Frontiers Sun, 07 Dec 2025 08:00:00 GMT
• fortress biotech charts a course to profitability with strong q3 results AD HOC NEWS Sat, 06 Dec 2025 08:00:00 GMT
• axsome therapeutics ceo tabuteau sells $11.6 million in shares by investing.com Investing.com India Fri, 05 Dec 2025 08:00:00 GMT
• axsome therapeutics ceo tabuteau sells $11.6 million in shares Investing.com Thu, 04 Dec 2025 08:00:00 GMT
• minerva jumps on phase iii funding, leading neuro stocks BioWorld News Thu, 04 Dec 2025 08:00:00 GMT
• mizuho securities sticks to its buy rating for axsome therapeutics (axsm) The Globe and Mail Thu, 04 Dec 2025 08:00:00 GMT
• tech emerges as a new frontier for digital therapeutics Endpoints News Tue, 02 Dec 2025 08:00:00 GMT
• esperion therapeutics stock hits near 1-year high as wall street sees strong risk-reward play on demand for cholesterol drug Stocktwits Wed, 26 Nov 2025 08:00:00 GMT
• avenue therapeutics leads six-month stock performance with 267.29% return Markets Mojo Tue, 25 Nov 2025 22:18:16 GMT
• axsome therapeutics stock reaches all-time high of 152.94 usd Investing.com Tue, 25 Nov 2025 08:00:00 GMT
• esperion therapeutics stock hits near 1-year high as wall street sees strong risk-reward play on demand for cholesterol drug Stocktwits Tue, 25 Nov 2025 08:00:00 GMT
• esperion therapeutics stock hits near 1-year high as wall street sees strong risk-reward play on demand for cholesterol drug Stocktwits Mon, 24 Nov 2025 15:07:38 GMT
• avenue therapeutics leads six-month stock performance with 253.98% return Markets Mojo Mon, 24 Nov 2025 08:00:00 GMT
• avenue therapeutics leads six-month stock performance with 257.7% return Markets Mojo Fri, 21 Nov 2025 22:07:18 GMT
• avenue therapeutics announces 2025 annual meeting date The Globe and Mail Wed, 19 Nov 2025 08:00:00 GMT
• village farms international leads with 282% return in recent performance surge Markets Mojo Tue, 18 Nov 2025 20:21:44 GMT
• village farms international leads with 275% return in recent performance surge Markets Mojo Mon, 17 Nov 2025 19:28:26 GMT
• axsome therapeutics stock hits all-time high at 144.19 usd Investing.com Mon, 17 Nov 2025 08:00:00 GMT
• sangamo therapeutics (nasdaq:sgmo) downgraded to strong sell rating by wall street zen MarketBeat Sun, 16 Nov 2025 08:00:00 GMT
• fortress biotech reports third quarter 2025 financial results and recent corporate highlights GlobeNewswire Fri, 14 Nov 2025 08:00:00 GMT
• avenue therapeutics leads six-month stock performance with 333.85% return Markets Mojo Fri, 14 Nov 2025 08:00:00 GMT
Avenue Therapeutics, Inc(NASDAQ:ATXI) 
Avenue Therapeutics, Inc., a specialty pharmaceutical company, acquires, licenses, develops, and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, which is in Phase III clinical trials to treat moderate to moderatel...
Website: http://www.avenuetx.com
Founded: 2015
Full Time Employees: 4
Sector: Healthcare
Industry: Biotechnology